This study advances our understanding of how <i>MSH3</i> deficiency contributes to genomic instability beyond canonically defined MSI loci, offering novel insights into the mutational landscapes of MMR-deficient tumors and how these <i>MSH3</i> mutations can potentially contribute to the outcome of AA CRC patients. Here, MSH3 is linked to colorectal carcinoma.